Kidney cancer trends and risk factors in Lebanon: a 12-year epidemiological study.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 17 12 2020
accepted: 15 11 2021
pubmed: 29 11 2021
medline: 27 1 2022
entrez: 28 11 2021
Statut: ppublish

Résumé

Lebanon has witnessed an increase in the rates of several cancer subtypes over the last years. The aim of this study is to examine the incidence rates of kidney cancer in Lebanon over 12 years and to compare them to other countries. Data were collected from the Lebanese National Cancer Registry (NCR) for the time period 2005-2016 (inclusive). Data from other countries were retrieved from an online database "Cancer Incidence in Five Continents." The age specific and age-standardized rates (ASR) were calculated and analyzed using Joinpoint regression. Kidney cancer ranked as the 10th commonest cancer among men and the 19th among women. An age-standardized rate of 3.54 (per 100,000) was obtained. The average ASR was 4.80 for men and 2.27 for women. Kidney cancer showed a significantly rising trend for both genders. Lebanon had the highest ASR for kidney cancer in men and the third highest in women among regional countries. Lebanon presented an average-to-high ASR for kidney cancer compared to regional countries. However, compared to countries worldwide, Lebanon had a below-average ASR. Nonetheless, with the rising kidney cancer trends, it is important to study the associated risk factors in order to develop proper preventive and screening measures and therefore decrease the incidence rates.

Identifiants

pubmed: 34839395
doi: 10.1007/s10552-021-01525-y
pii: 10.1007/s10552-021-01525-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-312

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Owens B (2016) Kidney cancer. Nature. https://doi.org/10.1038/537S97a
doi: 10.1038/537S97a pubmed: 27902684 pmcid: 27902684
Johansson ME, Axelson H (2013) Kidney cancer. Semin Cancer Biol 23(1):1–2. https://doi.org/10.1016/j.semcancer.2012.05.006
doi: 10.1016/j.semcancer.2012.05.006 pubmed: 22664338 pmcid: 22664338
Turajlic S, Swanton C, Boshoff C (2018) Kidney cancer: the next decade. J Exp Med 215(10):2477–2479. https://doi.org/10.1084/jem.20181617
doi: 10.1084/jem.20181617 pubmed: 30217855 pmcid: 30217855
Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490. https://doi.org/10.1056/NEJMra043172
doi: 10.1056/NEJMra043172 pubmed: 16339096 pmcid: 16339096
Chow WH, Gridley G, Fraumeni JF, Järvholm B (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343(18):1305–1311. https://doi.org/10.1056/NEJM200011023431804
doi: 10.1056/NEJM200011023431804 pubmed: 11058675 pmcid: 11058675
Wilson KM, Cho E (2016) Obesity and kidney cancer. Recent Results Cancer Res 208:81–93. https://doi.org/10.1007/978-3-319-42542-9_5
doi: 10.1007/978-3-319-42542-9_5 pubmed: 27909903 pmcid: 27909903
Liu X et al (2019) Dose-response relationships between cigarette smoking and kidney cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 142:86–93. https://doi.org/10.1016/j.critrevonc.2019.07.019
doi: 10.1016/j.critrevonc.2019.07.019 pubmed: 31387065 pmcid: 31387065
Ball MW, Shuch BM (2019) Inherited kidney cancer syndromes. Curr Opin Urol 29(4):334–343. https://doi.org/10.1097/MOU.0000000000000646
doi: 10.1097/MOU.0000000000000646 pubmed: 31083011 pmcid: 31083011
Jemal A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10–30. https://doi.org/10.3322/canjclin.55.1.10
doi: 10.3322/canjclin.55.1.10 pubmed: 15661684 pmcid: 15661684
Marenčák J, Ondrušová M, Ondruš D (2017) Recent overview of kidney cancer diagnostics and treatment. Klin Onkol Cas Ceske Slov Onkol Spolecnosti 30(3):175–181. https://doi.org/10.14735/amko2017175
doi: 10.14735/amko2017175
Powles T, ESMO Guidelines Committee (2021) Electronic address: clinicalguidelines@esmo.org. Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer: renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):422–423. https://doi.org/10.1016/j.annonc.2020.11.016
“United Nations. World Statistics Pocketbook [Lebanon].” http://data.un.org/CountryProfile.aspx/_Images/_Docs/CountryProfile.aspx?crName=Lebanon . Accessed 09 Aug 2020
“Ministry of Public Health. National Cancer Registry (NCR) of Lebanon.” http://www.moph.gov.lb . Accessed 09 Aug 2020
“World Population Prospects—Population Division—United Nations.” https://population.un.org/wpp/ . Accessed 15 June 2020
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (n.d.) Age standardization of rates: a new WHO standard, p 14
Segi M, Kyokai NT, Igakubu TD (2020) “Cancer mortality for selected sites in 24 countries.” Nagoya, Japan [etc.]: Japan Cancer Society [etc.], 1950, [Online]. Available: https://trove.nla.gov.au/version/14545131 . Accessed 15 June 2020
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z
doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z pubmed: 10649300 pmcid: 10649300
“Sample Joinpoint Analyses.” https://surveillance.cancer.gov/joinpoint/analyses.html . Accessed 15 June 2020
“Generate Random Countries.” https://www.randomlists.com/random-country . Accessed 15 June 2020
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J. Cancer incidence in five continents, vol XI
Dyba T, Hakulinen T (2000) Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 19(13):1741–1752. https://doi.org/10.1002/1097-0258(20000715)19:13%3c1741::aid-sim496%3e3.0.co;2-o
doi: 10.1002/1097-0258(20000715)19:13<1741::aid-sim496>3.0.co;2-o pubmed: 10861775 pmcid: 10861775
O’Lorcain P, Deady S, Comber H (2006) Mortality predictions for colon and anorectal cancer for Ireland, 2003–17. Colorectal Dis 8(5):393–401. https://doi.org/10.1111/j.1463-1318.2006.00951.x
doi: 10.1111/j.1463-1318.2006.00951.x pubmed: 16684083 pmcid: 16684083
Haddad FG, Kattan J, Kourie HR, El Rassy E, Assi T, Adib SM (2018) Geriatric cancer trends in the Middle-East: findings from Lebanese cancer projections until 2025. J Geriatr Oncol 9(2):120–123. https://doi.org/10.1016/j.jgo.2017.08.006
doi: 10.1016/j.jgo.2017.08.006 pubmed: 28877856 pmcid: 28877856
Khafaja S, Kourie HR, Matar D, Sader-Ghorra C, Kattan J (2015) Kidney cancer in Lebanon: a specific histological distribution? Asian Pac J Cancer Prev 16(1):363–365. https://doi.org/10.7314/APJCP.2015.16.1.363
doi: 10.7314/APJCP.2015.16.1.363 pubmed: 25640381 pmcid: 25640381
Alkhateeb SS, Alothman AS, Addar AM, Alqahtani RA, Mansi TM, Masuadi EM (2018) Kidney cancer in Saudi Arabia. A 25-year analysis of epidemiology and risk factors in a tertiary center. Saudi Med J 39(5):459–463. https://doi.org/10.15537/smj.2018.5.22641
doi: 10.15537/smj.2018.5.22641 pubmed: 29738004 pmcid: 29738004
Mirzaei M, Pournamdar Z, Salehiniya H (2015) Epidemiology and trends in incidence of kidney cancer in Iran. Asian Pac J Cancer Prev 16(14):5859–5861. https://doi.org/10.7314/apjcp.2015.16.14.5859
doi: 10.7314/apjcp.2015.16.14.5859 pubmed: 26320463 pmcid: 26320463
Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH (2019) Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-Based Study. Clin Genitourin Cancer 17(1):46-57.e5. https://doi.org/10.1016/j.clgc.2018.10.002
doi: 10.1016/j.clgc.2018.10.002 pubmed: 30391138 pmcid: 30391138
Luke C, Sargent N, Pittman K, Price T, Roder D (2011) Epidemiology of cancers of the kidney in an Australian population. Asian Pac J Cancer Prev 12(11):2893–2899
pubmed: 22393960 pmcid: 22393960
Scelo G, Li P, Chanudet E, Muller DC (2018) Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer. Eur Urol Focus. https://doi.org/10.1016/j.euf.2017.01.006
doi: 10.1016/j.euf.2017.01.006 pubmed: 28753845 pmcid: 28753845
Levi F et al (2008) The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101(8):949–958. https://doi.org/10.1111/j.1464-410X.2008.07451.x
doi: 10.1111/j.1464-410X.2008.07451.x pubmed: 18241251 pmcid: 18241251
Wong MCS et al (2017) Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci Rep 7(1):15698. https://doi.org/10.1038/s41598-017-15922-4
doi: 10.1038/s41598-017-15922-4 pubmed: 29146923 pmcid: 29146923
Alkhateeb SS, Alkhateeb JM, Alrashidi EA (2015) Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia. Saudi Med J 36(6):698–703. https://doi.org/10.15537/smj.2015.6.10841
doi: 10.15537/smj.2015.6.10841 pubmed: 25987112 pmcid: 25987112
Espey DK et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152. https://doi.org/10.1002/cncr.23044
doi: 10.1002/cncr.23044 pubmed: 17939129 pmcid: 17939129
Li J, Weir HK, Jim MA, King SM, Wilson R, Master VA (2014) Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990–2009. Am J Public Health 104(Suppl 3):S396–S403. https://doi.org/10.2105/AJPH.2013.301616
doi: 10.2105/AJPH.2013.301616 pubmed: 24754655 pmcid: 24754655
Li P et al (2015) Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol 67(6):1134–1141. https://doi.org/10.1016/j.eururo.2014.11.001
doi: 10.1016/j.eururo.2014.11.001 pubmed: 25465966 pmcid: 25465966
Azawi NH, Joergensen SM, Jensen NV, Clark PE, Lund L, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in kidney cancer among the elderly in Denmark, 1980–2012. Acta Oncol. https://doi.org/10.3109/0284186X.2015.1115121
doi: 10.3109/0284186X.2015.1115121
Capitanio U et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75(1):74–84. https://doi.org/10.1016/j.eururo.2018.08.036
doi: 10.1016/j.eururo.2018.08.036 pubmed: 30243799 pmcid: 30243799
Decastro GJ, McKiernan JM (2008) Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin N Am. https://doi.org/10.1016/j.ucl.2008.07.005
doi: 10.1016/j.ucl.2008.07.005
Linehan JA, Nguyen MM (2009) Kidney cancer: the new landscape. Curr Opin Urol 19(2):133–137. https://doi.org/10.1097/MOU.0b013e328323f5ab
doi: 10.1097/MOU.0b013e328323f5ab pubmed: 19188766 pmcid: 19188766
Weikert S, Ljungberg B (2010) Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol 28(3):247–252. https://doi.org/10.1007/s00345-010-0555-1
doi: 10.1007/s00345-010-0555-1 pubmed: 20390283 pmcid: 20390283
Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA (2019) Systematic review of modifiable risk factors for kidney cancer. Urol Oncol 37(6):359–371. https://doi.org/10.1016/j.urolonc.2018.12.008
doi: 10.1016/j.urolonc.2018.12.008 pubmed: 30685335 pmcid: 30685335
Petejova N, Martinek A (2016) Renal cell carcinoma: review of etiology, pathophysiology and risk factors. Biomed Pap 160(2):183–194. https://doi.org/10.5507/bp.2015.050
doi: 10.5507/bp.2015.050
Chow W-H, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7(5):245–257. https://doi.org/10.1038/nrurol.2010.46
doi: 10.1038/nrurol.2010.46 pubmed: 20448658 pmcid: 20448658
Everatt R, Virvičiūtė D, Tamošiūnas A (2019) Body mass index and other risk factors for kidney cancer in men: a cohort study in Lithuania. Cent Eur J Public Health 27(4):272–278. https://doi.org/10.21101/cejph.a5080
doi: 10.21101/cejph.a5080 pubmed: 31951685 pmcid: 31951685
Sibai AM et al (2016) Cigarette smoking in a Middle Eastern country and its association with hospitalisation use: a nationwide cross-sectional study. BMJ Open 6(4):e009881. https://doi.org/10.1136/bmjopen-2015-009881
doi: 10.1136/bmjopen-2015-009881 pubmed: 27059466 pmcid: 27059466
Jawad M, Charide R, Waziry R, Darzi A, Ballout RA, Akl EA (2018) The prevalence and trends of waterpipe tobacco smoking: a systematic review. PloS One 13(2):e0192191. https://doi.org/10.1371/journal.pone.0192191
Chidiac A, Tamim H, Kanso M, Tfayli A (2016) Smoking among Lebanese medical students: prevalence and attitudes. Ann Thorac Med 11(3):183. https://doi.org/10.4103/1817-1737.185757
doi: 10.4103/1817-1737.185757 pubmed: 27512507 pmcid: 27512507
Musaiger AO (2011) Overweight and obesity in Eastern Mediterranean region: prevalence and possible causes. J Obes 2011:407237. https://doi.org/10.1155/2011/407237
doi: 10.1155/2011/407237 pubmed: 21941635 pmcid: 21941635
Nasreddine L, Naja F, Chamieh MC, Adra N, Sibai A-M, Hwalla N (2012) Trends in overweight and obesity in Lebanon: evidence from two national cross-sectional surveys (1997 and 2009). BMC Public Health 12:798. https://doi.org/10.1186/1471-2458-12-798
doi: 10.1186/1471-2458-12-798 pubmed: 22984791 pmcid: 22984791
Chamieh MC, Moore HJ, Summerbell C, Tamim H, Sibai AM, Hwalla N (2015) Diet, physical activity and socio-economic disparities of obesity in Lebanese adults: findings from a national study. BMC Public Health. https://doi.org/10.1186/s12889-015-1605-9
doi: 10.1186/s12889-015-1605-9 pubmed: 25880751 pmcid: 25880751
Tahbaz R, Schmid M, Merseburger AS (2018) Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol 28(1):62–79. https://doi.org/10.1097/MOU.0000000000000454
doi: 10.1097/MOU.0000000000000454 pubmed: 29059103 pmcid: 29059103
Gray RE, Harris GT (2019) Renal cell carcinoma: diagnosis and management. Am Fam Physician 99(3):179–184. Erratum in: Am Fam Physician. 2019 Jun 15;99(12):732

Auteurs

Elise Assouad (E)

Faculty of Medicine, Lebanese American University, Byblos, Lebanon.

Said El Hage (S)

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.
Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.
INSPECT-LB (Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie), Beirut, Lebanon.

Steven Safi (S)

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon. Stevensafi99@gmail.com.

Antonio El Kareh (A)

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Elie Mokled (E)

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Pascale Salameh (P)

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.
Faculty of Pharmacy, Lebanese University, Hadath, Lebanon.
INSPECT-LB (Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie), Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH